Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open‐label phase 2 trial
暂无分享,去创建一个
K. Tamura | H. Mukai | K. Hasegawa | H. Nomura | H. Minami | Koji Matsumoto | N. Katsumata | S. Takahashi | K. Hasegawa